Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan S Jaffe

Showing results (81-90 of 590) with videos related to

Pageof 59
Sort By:
Clinical Biochemistry|June 15, 2014
Men are different than women: it's true for cardiac troponin tooFred S Apple, Allan S Jaffe
The Canadian Journal of Cardiology|May 16, 2023
Troponin T Levels and When to Peek Using CMR in Patients With MINOCAPeter A Kavsak, Allan S Jaffe
European Heart Journal Open|August 4, 2022
An enhanced ceramide-based approach for primary prevention of atherosclerotic eventsVlad C Vasile, Allan S Jaffe
JACC. Cardiooncology|March 21, 2024
Cancer Therapy-Related Cardiac Dysfunction: Expanding the Horizon of Cardiac Troponin in Clinical PracticeLaura De Michieli, Allan S Jaffe
Revista Espanola De Cardiologia|July 9, 2010
High sensitivity troponin in chest pain and acute coronary syndromes. A step forward?Allan S Jaffe, Jordi Ordonez-Llanos
Clinical Chemistry|March 11, 2017
Using Biomarkers to Guide Heart Failure TherapyAllan S Jaffe, James L Januzzi
Clinical Chemistry|April 30, 2008
Variability of lipoprotein-associated phospholipase A2 measurementsJoseph P McConnell, Allan S Jaffe
The Medical Clinics of North America|July 21, 2007
The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromesAmy K Saenger, Allan S Jaffe
Clinical Chemistry|December 3, 2008
The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial?Joseph P McConnell, Allan S Jaffe
Clinical Chemistry|October 7, 2011
High-sensitivity cardiac troponin assays--change is importantPeter A Kavsak, Allan S Jaffe
Pageof 59

Showing results (81-90 of 590) with videos related to

Sort By:
Pageof 59
Clinical Biochemistry|June 15, 2014
Men are different than women: it's true for cardiac troponin tooFred S Apple, Allan S Jaffe
The Canadian Journal of Cardiology|May 16, 2023
Troponin T Levels and When to Peek Using CMR in Patients With MINOCAPeter A Kavsak, Allan S Jaffe
European Heart Journal Open|August 4, 2022
An enhanced ceramide-based approach for primary prevention of atherosclerotic eventsVlad C Vasile, Allan S Jaffe
JACC. Cardiooncology|March 21, 2024
Cancer Therapy-Related Cardiac Dysfunction: Expanding the Horizon of Cardiac Troponin in Clinical PracticeLaura De Michieli, Allan S Jaffe
Revista Espanola De Cardiologia|July 9, 2010
High sensitivity troponin in chest pain and acute coronary syndromes. A step forward?Allan S Jaffe, Jordi Ordonez-Llanos
Clinical Chemistry|March 11, 2017
Using Biomarkers to Guide Heart Failure TherapyAllan S Jaffe, James L Januzzi
Clinical Chemistry|April 30, 2008
Variability of lipoprotein-associated phospholipase A2 measurementsJoseph P McConnell, Allan S Jaffe
The Medical Clinics of North America|July 21, 2007
The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromesAmy K Saenger, Allan S Jaffe
Clinical Chemistry|December 3, 2008
The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial?Joseph P McConnell, Allan S Jaffe
Clinical Chemistry|October 7, 2011
High-sensitivity cardiac troponin assays--change is importantPeter A Kavsak, Allan S Jaffe
Pageof 59